Novel Inhibitors of Staphylococcus aureus Virulence Gene Expression and Biofilm Formation

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Ma, Yibao ^a   Xu, Yuanxi ^a   Yestrepsky, Bryan D ^b   Sorenson, Roderick J ^b   Chen, Meng ^c   Larsen, Scott D ^b   Sun, Hongmin ^a  

^a University of Missouri   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c Nanova Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CCG 203592; CCG 205363; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL VIRULENCE; BIOFILM; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG SCREENING; DRUG STRUCTURE; GENE EXPRESSION; HUMAN; HUMAN CELL; NONHUMAN; STAPHYLOCOCCUS AUREUS; TOXICITY TESTING;

ANTI-BACTERIAL AGENTS; BIOFILMS; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; QUINAZOLINES; SMALL MOLECULE LIBRARIES; STREPTOKINASE;

EID: 84867502614     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047255     Document Type: Article

References (74)

1. Lowy FD, (1998) Staphylococcus aureus infections. N. Engl. J. Med. 339: 520-532.
2. Chambers HF, DeLeo FR, (2009) Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat. Rev. Microbiol. 7: 629-641.
3. Agarwal A, Singh KP, Jain A, (2010) Medical significance and management of staphylococcal biofilm. FEMS Immunol. Med. Microbiol. 58: 147-160.
4. Costerton JW, Stewart PS, Greenberg EP, (1999) Bacterial biofilms: a common cause of persistent infections. Science 284: 1318-1322.
5. Donlan RM, (2001) Biofilms and device-associated infections. Emerg. Infect. Dis. 7: 277-281.
6. Maki DG, Kluger DM, Crnich CJ, (2006) The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin. Proc. 81: 1159-1171.
7. Otto M, (2008) Staphylococcal biofilms. Curr. Top. Microbiol. Immunol. 322: 207-228.
8. Otto M (2009) Looking toward basic science for potential drug discovery targets against community-associated MRSA. Med. Res. Rev.: 1-22.
9. Donlan RM, (2002) Biofilms: microbial life on surfaces. Emerg. Infect. Dis. 8: 881-890.
10. Davies D, (2003) Understanding biofilm resistance to antibacterial agents. Nat. Rev. Drug Discov. 2: 114-122.
11. Grundmann H, ires-de-Sousa M, Boyce J, Tiemersma E, (2006) Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet 368: 874-885.
12. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, et al. (2007) Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298: 1763-1771.
13. Otto M, (2004) Virulence factors of the coagulase-negative staphylococci. Front Biosci 9: 841-863.
14. Alanis AJ, (2005) Resistance to antibiotics: are we in the post-antibiotic era? Arch. Med. Res. 36: 697-705.
15. Bax R, Mullan N, Verhoef J, (2000) The millennium bugs-the need for and development of new antibacterials. Int. J. Antimicrob. Agents 16: 51-59.
16. Norrby SR, Nord CE, Finch R, (2005) Lack of development of new antimicrobial drugs: a potential serious threat to public health. Lancet Infect. Dis. 5: 115-119.
17. Waldor MK, (2006) Disarming pathogens-a new approach for antibiotic development. N. Engl. J. Med. 354: 296-297.
18. Hung DT, Shakhnovich EA, Pierson E, Mekalanos JJ, (2005) Small-molecule inhibitor of Vibrio cholerae virulence and intestinal colonization. Science 310: 670-674.
19. Rasko DA, Moreira CG, Li dR, Reading NC, Ritchie JM, et al. (2008) Targeting QseC signaling and virulence for antibiotic development. Science 321: 1078-1080.
20. Sun H, Xu Y, Sitkiewicz I, Ma Y, Wang X, et al. (2012) Inhibitor of streptokinase gene expression improves survival after group A streptococcus infection in mice. Proc Natl Acad Sci U S A 109: 3469-3474.
21. Sun H, Ringdahl U, Homeister JW, Fay WP, Engleberg NC, et al. (2004) Plasminogen is a critical host pathogenicity factor for group A streptococcal infection. Science 305: 1283-1286.
22. Sun H, (2011) Exploration of the host haemostatic system by group A streptococcus: implications in searching for novel antimicrobial therapies. J Thromb Haemost 9 (Suppl 1): 189-194.
23. Sun H, Wang X, Degen JL, Ginsburg D, (2009) Reduced thrombin generation increases host susceptibility to group A streptococcal infection. Blood 113: 1358-1364.
24. Deighton MA, Capstick J, Domalewski E, van NT, (2001) Methods for studying biofilms produced by Staphylococcus epidermidis. Methods Enzymol. 336: 177-195.
25. Jiang P, Li J, Han F, Duan G, Lu X, et al. (2011) Antibiofilm activity of an exopolysaccharide from marine bacterium Vibrio sp. QY101. PLoS One 6: e18514.
26. Shanks RM, Donegan NP, Graber ML, Buckingham SE, Zegans ME, et al. (2005) Heparin stimulates Staphylococcus aureus biofilm formation. Infect Immun 73: 4596-4606.
27. Herbert S, Ziebandt AK, Ohlsen K, Schafer T, Hecker M, et al. (2010) Repair of global regulators in Staphylococcus aureus 8325 and comparative analysis with other clinical isolates. Infect Immun 78: 2877-2889.
28. Donlan RM, Costerton JW, (2002) Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15: 167-193.
29. Wang R, Neoh KG, Shi Z, Kang ET, Tambyah PA, et al. (2012) Inhibition of Escherichia coli and Proteus mirabilis adhesion and biofilm formation on medical grade silicone surface. Biotechnol Bioeng 109: 336-345.
30. O'Gara JP, (2007) ica and beyond: biofilm mechanisms and regulation in Staphylococcus epidermidis and Staphylococcus aureus. FEMS Microbiol Lett 270: 179-188.
31. Peschel A, Otto M, Jack RW, Kalbacher H, Jung G, et al. (1999) Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J Biol Chem 274: 8405-8410.
32. Biswas R, Voggu L, Simon UK, Hentschel P, Thumm G, et al. (2006) Activity of the major staphylococcal autolysin Atl. FEMS Microbiol.Lett. 259: 260-268.
33. Wang R, Braughton KR, Kretschmer D, Bach TH, Queck SY, et al. (2007) Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat. Med 13: 1510-1514.
34. Rasko DA, Sperandio V, (2009) Novel approaches to bacterial infection therapy by interfering with cell-to-cell signaling. Curr. Protoc. Microbiol. Chapter 17: Unit17.
35. Cramton SE, Gerke C, Schnell NF, Nichols WW, Gotz F, (1999) The intercellular adhesion (ica) locus is present in Staphylococcus aureus and is required for biofilm formation. Infect Immun 67: 5427-5433.
36. Gross M, Cramton SE, Gotz F, Peschel A, (2001) Key role of teichoic acid net charge in Staphylococcus aureus colonization of artificial surfaces. Infection and Immunity 69: 3423-3426.
37. Houston P, Rowe SE, Pozzi C, Waters EM, O'Gara JP, (2011) Essential role for the major autolysin in the fibronectin-binding protein-mediated Staphylococcus aureus biofilm phenotype. Infect Immun 79: 1153-1165.
38. Merino N, Toledo-Arana A, Vergara-Irigaray M, Valle J, Solano C, et al. (2009) Protein A-mediated multicellular behavior in Staphylococcus aureus. J. Bacteriol. 191: 832-843.
39. Hartford OM, Wann ER, Hook M, Foster TJ, (2001) Identification of residues in the Staphylococcus aureus fibrinogen-binding MSCRAMM clumping factor A (ClfA) that are important for ligand binding. J Biol Chem 276: 2466-2473.
40. Patti JM, Allen BL, McGavin MJ, Hook M, (1994) MSCRAMM-mediated adherence of microorganisms to host tissues. Annu Rev Microbiol 48: 585-617.
41. Zhang L, Xiang H, Gao J, Hu J, Miao S, et al. (2010) Purification, characterization, and crystallization of the adhesive domain of SdrD from Staphylococcus aureus. Protein Expr Purif 69: 204-208.
42. Rohde H, Burandt EC, Siemssen N, Frommelt L, Burdelski C, et al. (2007) Polysaccharide intercellular adhesin or protein factors in biofilm accumulation of Staphylococcus epidermidis and Staphylococcus aureus isolated from prosthetic hip and knee joint infections. Biomaterials 28: 1711-1720.
43. Shaw L, Golonka E, Potempa J, Foster SJ, (2004) The role and regulation of the extracellular proteases of Staphylococcus aureus. Microbiology 150: 217-228.
44. Shaw LN, Golonka E, Szmyd G, Foster SJ, Travis J, et al. (2005) Cytoplasmic control of premature activation of a secreted protease zymogen: deletion of staphostatin B (SspC) in Staphylococcus aureus 8325-4 yields a profound pleiotropic phenotype. J Bacteriol 187: 1751-1762.
45. Hecker M, Pane-Farre J, Volker U, (2007) SigB-dependent general stress response in Bacillus subtilis and related gram-positive bacteria. Annu Rev Microbiol 61: 215-236.
46. Lauderdale KJ, Boles BR, Cheung AL, Horswill AR, (2009) Interconnections between Sigma B, agr, and proteolytic activity in Staphylococcus aureus biofilm maturation. Infect Immun 77: 1623-1635.
47. Novick RP, Geisinger E, (2008) Quorum sensing in staphylococci. Annu. Rev. Genet. 42: 541-564.
48. Boles BR, Horswill AR, (2008) Agr-mediated dispersal of Staphylococcus aureus biofilms. PLoS. Pathog. 4: e1000052.
49. Boles BR, Horswill AR (2011) Staphylococcal biofilm disassembly. Trends Microbiol.
50. Yarwood JM, Bartels DJ, Volper EM, Greenberg EP, (2004) Quorum sensing in Staphylococcus aureus biofilms. J Bacteriol 186: 1838-1850.
51. Caiazza NC, O'Toole GA, (2003) Alpha-toxin is required for biofilm formation by Staphylococcus aureus. J Bacteriol 185: 3214-3217.
52. Periasamy S, Joo HS, Duong AC, Bach TH, Tan VY, et al. (2012) How Staphylococcus aureus biofilms develop their characteristic structure. Proc Natl Acad Sci U S A 109: 1281-1286.
53. Mann EE, Rice KC, Boles BR, Endres JL, Ranjit D, et al. (2009) Modulation of eDNA release and degradation affects Staphylococcus aureus biofilm maturation. PLoS ONE. 4: e5822.
54. Rice KC, Mann EE, Endres JL, Weiss EC, Cassat JE, et al. (2007) The cidA murein hydrolase regulator contributes to DNA release and biofilm development in Staphylococcus aureus. Proc Natl Acad Sci U S A 104: 8113-8118.
55. Majerczyk CD, Sadykov MR, Luong TT, Lee C, Somerville GA, et al. (2008) Staphylococcus aureus CodY negatively regulates virulence gene expression. J. Bacteriol. 190: 2257-2265.
56. Tu Quoc PH, Genevaux P, Pajunen M, Savilahti H, Georgopoulos C, et al. (2007) Isolation and characterization of biofilm formation-defective mutants of Staphylococcus aureus. Infect Immun 75: 1079-1088.
57. Regassa LB, Novick RP, Betley MJ, (1992) Glucose and nonmaintained pH decrease expression of the accessory gene regulator (agr) in Staphylococcus aureus. Infect Immun 60: 3381-3388.
58. Palmqvist N, Foster T, Tarkowski A, Josefsson E, (2002) Protein A is a virulence factor in Staphylococcus aureus arthritis and septic death. Microb Pathog 33: 239-249.
59. Patel AH, Nowlan P, Weavers ED, Foster T, (1987) Virulence of protein A-deficient and alpha-toxin-deficient mutants of Staphylococcus aureus isolated by allele replacement. Infect Immun 55: 3103-3110.
60. Bubeck WJ, Bae T, Otto M, DeLeo FR, Schneewind O, (2007) Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat. Med. 13: 1405-1406.
61. Bubeck WJ, Patel RJ, Schneewind O, (2007) Surface proteins and exotoxins are required for the pathogenesis of Staphylococcus aureus pneumonia. Infection and Immunity 75: 1040-1044.
62. Kobayashi SD, DeLeo FR, (2009) An update on community-associated MRSA virulence. Curr. Opin. Pharmacol. 9: 545-551.
63. Smagur J, Guzik K, Bzowska M, Kuzak M, Zarebski M, et al. (2009) Staphylococcal cysteine protease staphopain B (SspB) induces rapid engulfment of human neutrophils and monocytes by macrophages. Biol Chem 390: 361-371.
64. Musser JM, Hauser AR, Kim MH, Schlievert PM, Nelson K, et al. (1991) Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proc. Natl. Acad. Sci. U.S.A 88: 2668-2672.
65. Duthie ES, Lorenz LL, (1952) Staphylococcal coagulase; mode of action and antigenicity. J Gen Microbiol 6: 95-107.
66. Peng HL, Novick RP, Kreiswirth B, Kornblum J, Schlievert P, (1988) Cloning, characterization, and sequencing of an accessory gene regulator (agr) in Staphylococcus aureus. J Bacteriol 170: 4365-4372.
67. Novick RP, Richmond MH, (1965) Nature and Interactions of the Genetic Elements Governing Penicillinase Synthesis in Staphylococcus Aureus. J Bacteriol 90: 467-480.
68. Cramton SE, Gerke C, Gotz F, (2001) In vitro methods to study staphylococcal biofilm formation. Methods Enzymol. 336: 239-255.
69. McGillivray SM, Tran DN, Ramadoss NS, Alumasa JN, Okumura CY, et al. (2012) Pharmacological Inhibition of the ClpXP Protease Increases Bacterial Susceptibility to Host Cathelicidin Antimicrobial Peptides and Cell Envelope-Active Antibiotics. Antimicrob Agents Chemother 56: 1854-1861.
70. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
71. Tan H, Peng Z, Li Q, Xu X, Guo S, et al. (2012) The use of quaternised chitosan-loaded PMMA to inhibit biofilm formation and downregulate the virulence-associated gene expression of antibiotic-resistant staphylococcus. Biomaterials 33: 365-377.
72. Queck SY, Jameson-Lee M, Villaruz AE, Bach TH, Khan BA, et al. (2008) RNAIII-independent target gene control by the agr quorum-sensing system: insight into the evolution of virulence regulation in Staphylococcus aureus. Mol. Cell 32: 150-158.
73. Rice K, Peralta R, Bast D, de Azavedo J, McGavin MJ, (2001) Description of staphylococcus serine protease (ssp) operon in Staphylococcus aureus and nonpolar inactivation of sspA-encoded serine protease. Infect Immun 69: 159-169.
74. Boles BR, Thoendel M, Roth AJ, Horswill AR, (2010) Identification of genes involved in polysaccharide-independent Staphylococcus aureus biofilm formation. PLoS One 5: e10146.